Skip to main content

Market Overview

Recap: Assertio Holdings Q2 Earnings

Share:

Shares of Assertio Holdings (NASDAQ:ASRT) moved higher by 0.9% in pre-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share were down 33.33% over the past year to ($0.28), which missed the estimate of ($0.03).

Revenue of $20,617,000 decreased by 63.96% from the same period last year, which missed the estimate of $25,330,000.

Outlook

Assertio Holdings hasn't issued any earnings guidance for the time being.

Revenue guidance hasn't been issued by the company for now.

How To Listen To The Conference Call

Date: Aug 07, 2020

Time: 08:30 AM

ET Webcast URL: https://edge.media-server.com/mmc/p/onwswjoj

Price Action

Company's 52-week high was at $2.94

52-week low: $0.55

Price action over last quarter: Up 16.49%

Company Overview

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

 

Related Articles (ASRT)

View Comments and Join the Discussion!

Posted-In: Earnings News

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com